TY  - JOUR
AU  - Cong, Xiaojing
AU  - Cremer, Christian
AU  - Nachreiner, Thomas
AU  - Barth, Stefan
AU  - Carloni, Paolo
TI  - Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations
JO  - Protein science
VL  - 25
IS  - 8
SN  - 0961-8368
CY  - Hoboken, NJ
PB  - Wiley
M1  - FZJ-2016-05801
SP  - 1451 - 1460
PY  - 2016
AB  - Targeted human cytolytic fusion proteins (hCFPs) represent a new generation of immunotoxins (ITs) for the specific targeting and elimination of malignant cell populations. Unlike conventional ITs, hCFPs comprise a human/humanized target cell-specific binding moiety (e.g., an antibody or a fragment thereof) fused to a human proapoptotic protein as the cytotoxic domain (effector domain). Therefore, hCFPs are humanized ITs expected to have low immunogenicity. This reduces side effects and allows long-term application. The human ribonuclease angiogenin (Ang) has been shown to be a promising effector domain candidate. However, the application of Ang-based hCFPs is largely hampered by the intracellular placental ribonuclease inhibitor (RNH1). It rapidly binds and inactivates Ang. Mutations altering Ang's affinity for RNH1 modulate the cytotoxicity of Ang-based hCFPs. Here we perform in total 2.7 µs replica-exchange molecular dynamics simulations to investigate some of these mutations—G85R/G86R (GGRRmut), Q117G (QGmut), and G85R/G86R/Q117G (GGRR/QGmut). GGRRmut turns out to perturb greatly the overall Ang-RNH1 interactions, whereas QGmut optimizes them. Combining QGmut with GGRRmut compensates the effects of the latter. Our results explain the in vitro finding that, while Ang GGRRmut-based hCFPs resist RNH1 inhibition remarkably, Ang WT- and Ang QGmut-based ones are similarly sensitive to RNH1 inhibition, whereas Ang GGRR/QGmut-based ones are only slightly resistant. This work may help design novel Ang mutants with reduced affinity for RNH1 and improved cytotoxicity.
LB  - PUB:(DE-HGF)16
UR  - <Go to ISI:>//WOS:000380068700009
C6  - pmid:27110669
DO  - DOI:10.1002/pro.2941
UR  - https://juser.fz-juelich.de/record/820508
ER  -